Nexus Surgical and Medicare Inc Stock Price Today (NSE: NEXUSSURGL)
Fundamental Score
Nexus Surgical and Medicare Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nexus Surgical and Medicare Inc share price today is ₹30.67, down 4.78% on NSE/BSE as of 18 September 2026. Nexus Surgical and Medicare Inc (NEXUSSURGL) is a Small-cap company in the Other Financial Services sector with a market capitalisation of ₹16.78 (Cr). The 52-week high for NEXUSSURGL share price is ₹35.79 and the 52-week low is ₹13.26. At a P/E ratio of 21.31x, NEXUSSURGL is currently trading below its industry average P/E of 27.57x. The company has a Return on Equity (ROE) of 51.69% and a debt-to-equity ratio of N/A.
Nexus Surgical and Medicare Inc Share Price Chart — NSE/BSE Historical Performance
Nexus Surgical and Medicare Inc share price chart: 83.17% return over the past month. 52-week high ₹35.79, 52-week low ₹13.26.
Nexus Surgical and Medicare Inc — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹33.00 | ₹33.80 | ₹30.60 | ₹30.67 | 6.88K (Cr) | |
| ₹32.43 | ₹34.74 | ₹31.44 | ₹32.21 | 9.70K (Cr) | |
| ₹35.79 | ₹35.79 | ₹32.45 | ₹33.09 | 10.59K (Cr) | |
| ₹34.00 | ₹35.13 | ₹34.00 | ₹34.15 | 10.83K (Cr) | |
| ₹35.22 | ₹35.22 | ₹33.46 | ₹33.46 | 5.58K (Cr) | |
| ₹31.50 | ₹35.22 | ₹31.50 | ₹35.22 | 23.59K (Cr) | |
| ₹35.20 | ₹35.40 | ₹31.01 | ₹32.02 | 62.45K (Cr) | |
| ₹31.00 | ₹33.74 | ₹30.00 | ₹33.74 | 96.02K (Cr) | |
| ₹24.51 | ₹30.00 | ₹23.15 | ₹28.12 | 29.27K (Cr) | |
| ₹28.60 | ₹28.60 | ₹24.31 | ₹25.50 | 29.92K (Cr) |
Nexus Surgical and Medicare Inc — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹21.30 | ₹35.79 | ₹21.20 | ₹30.67 | +43.99% | |
| ₹19.05 | ₹25.30 | ₹17.00 | ₹22.43 | +17.74% | |
| ₹21.20 | ₹23.95 | ₹17.00 | ₹18.71 | -11.75% | |
| ₹19.90 | ₹22.40 | ₹18.51 | ₹21.00 | +5.53% | |
| ₹20.39 | ₹25.50 | ₹18.02 | ₹19.90 | -2.40% | |
| ₹17.05 | ₹21.46 | ₹17.01 | ₹20.40 | +19.65% | |
| ₹17.65 | ₹19.50 | ₹16.02 | ₹16.03 | -9.18% | |
| ₹17.01 | ₹19.99 | ₹16.01 | ₹18.62 | +9.47% | |
| ₹19.40 | ₹19.40 | ₹15.26 | ₹17.75 | -8.51% | |
| ₹16.02 | ₹17.50 | ₹13.26 | ₹17.50 | +9.24% | |
| ₹18.10 | ₹19.99 | ₹14.55 | ₹16.00 | -11.60% | |
| ₹17.01 | ₹19.95 | ₹14.02 | ₹18.12 | +6.53% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Assets (ROA)
Bank profit generated relative to total assets
Net Profit Margin
Net profit as a percentage of reported revenue/income
Dividend Yield
Annual dividend as % of current share price
Nexus Surgical and Medicare Inc Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Price to Book (P/B)
Share price ÷ book value per share — key bank valuation metric
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt/Equity, interest coverage and industrial free-cash-flow ratios are not shown for banks because deposits and borrowings are part of the core lending business. Bull Run uses ROA, ROE, P/B and net profit margin above for bank analysis.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nexus Surgical and Medicare Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NEXUSSURGL across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (51.69%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Attractive Valuation (P/E: 21.31 vs Industry: 27.57)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (31.15%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (47.81%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (16.04% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (37.60% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (37.60% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
High Price-to-Book Ratio (9.32x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Low Promoter Commitment (18.73%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Nexus Surgical and Medicare Inc vs Other Financial Services Peers
Peer Comparison - Other Financial Services
Compare Nexus Surgical and Medicare Inc with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Nexus Surgical and Medicare IncNexus Surgical ...Selected✓ NEXUSSURGL • 538874 | 63.8/100 | ₹30.67₹31 | ₹16.78₹16.78 | 21.31Average 21.3 Average | 51.69%Excellent 51.69% Excellent | — — | — — | 37.60%Excellent 37.60% Excellent | 16.04%Excellent 16.04% Excellent | 0.00% |
Crisil LimitedCrisil Limited... CRISIL • 500092 | 66.4/100 | ₹4687.90₹4688 | ₹34268.55₹34268.55 | 38.77Average 38.8 Average | 27.37%Excellent 27.37% Excellent | — — | — — | 14.40%Good 14.40% Good | 12.99%Good 12.99% Good | 0.59% |
RRPSemiconductorRRPSemiconducto... RRPS • 504346 | 8/100 | ₹15.00₹15 | ₹12118.00₹12118.00 | — — | -61.01%Poor -61.01% Poor | — — | — — | — — | — — | 0.00% |
Dhani Services LtdDhani Services ... DHANI • 532960 | 20.9/100 | ₹51.06₹51 | ₹3896.81₹3896.81 | 114.92Average 114.9 Average | -1.81%Poor -1.81% Poor | 1.39%Poor 1.39% Poor | 0.18Excellent 0.2 Excellent | — — | -32.89%Poor -32.89% Poor | 0.00% |
COLAB PLATFORMS LIMITEDCOLAB PLATFORMS... COLAB • 542866 | 45/100 | ₹132.40₹132 | ₹2700.96₹2700.96 | 553.76Average 553.8 Average | 17.57%Good 17.57% Good | — — | — — | 198.76%Excellent 198.76% Excellent | 356.32%Excellent 356.32% Excellent | 0.01% |
Algoquant Fintech LimitedAlgoquant Finte... ALGOQUANT • 505725 | 57.7/100 | ₹63.94₹64 | ₹1797.33₹1797.33 | 45.67Average 45.7 Average | 27.69%Excellent 27.69% Excellent | — — | — — | 67.14%Excellent 67.14% Excellent | 111.83%Excellent 111.83% Excellent | 0.00% |
LKP Finance LtdLKP Finance Ltd... LKPFIN • 507912 | 53.9/100 | ₹189.35₹189 | ₹1251.64₹1251.64 | 57.39Average 57.4 Average | 5.24%Poor 5.24% Poor | 6.77%Poor 6.77% Poor | 0.00Excellent 0.0 Excellent | -18.20%Poor -18.20% Poor | 31.70%Excellent 31.70% Excellent | 0.00% |
Centrum Capital LimitedCentrum Capital... CENTRUM • 501150 | 0/100 | ₹22.33₹22 | ₹1087.09₹1087.09 | — — | -46.79%Poor -46.79% Poor | — — | — — | — — | 49.72%Excellent 49.72% Excellent | 0.00% |
Prime Securities LimitedPrime Securitie... PRIMESECU • 500337 | 35.4/100 | ₹278.90₹279 | ₹946.59₹946.59 | 169.03Average 169.0 Average | 6.69%Poor 6.69% Poor | — — | — — | 2.90%Average 2.90% Average | 25.66%Excellent 25.66% Excellent | 0.54% |
85/100 | ₹847.95₹848 | ₹903.49₹903.49 | 27.35Average 27.4 Average | 27.72%Excellent 27.72% Excellent | — — | — — | 24.61%Excellent 24.61% Excellent | 23.58%Excellent 23.58% Excellent | 2.10% | |
63.7/100 | ₹322.55₹323 | ₹614.86₹614.86 | 21.22Average 21.2 Average | 20.57%Excellent 20.57% Excellent | 27.26%Excellent 27.26% Excellent | 0.17Excellent 0.2 Excellent | 31.11%Excellent 31.11% Excellent | 48.53%Excellent 48.53% Excellent | 0.00% | |
Top Other Financial Services Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Crisil Limited share price34268.55 Cr
- RRPSemiconductor share price12118.00 Cr
- Dhani Services Ltd share price3896.81 Cr
- COLAB PLATFORMS LIMITED share price2700.96 Cr
- Algoquant Fintech Limited share price1797.33 Cr
Nexus Surgical and Medicare Inc PE Ratio History
Historical price-to-earnings ratio for NEXUSSURGL — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.39 | ₹27.68 | 71x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Nexus Surgical and Medicare Inc Quarterly Performance
Latest quarterly metrics for NEXUSSURGL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
47.81%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
31.15%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
16.04%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
37.60%
Compounded annual net profit growth over 5 years
Nexus Surgical and Medicare Inc Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NEXUSSURGL — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Nexus Surgical and Medicare Inc Financial Statements
Annual income statement, balance sheet and cash flow for Nexus Surgical and Medicare Inc (NEXUSSURGL) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Nexus Surgical and Medicare Inc
About NEXUSSURGL (Nexus Surgical and Medicare Inc)
Nexus Surgical and Medicare Inc. (NEXUSSURGL) is a multifaceted entity operating within the financial services sector, strategically positioned to bridge the gap between healthcare... and capital markets. NEXUSSURGL specializes in facilitating financial solutions that empower healthcare providers and institutions. The company employs innovative financial instruments and strategic partnerships to optimize resource allocation, enabling advancements in patient care and medical technology adoption. By understanding the intricate financial needs of the healthcare landscape, NEXUSSURGL provides tailored services designed to foster stability and growth within the medical community. NEXUSSURGL focuses on creating financial ecosystems that support the healthcare industry's long-term viability. This involves connecting investors with promising ventures, streamlining financial processes for medical facilities, and promoting responsible financial practices within the sector. The company’s commitment to ethical and transparent operations ensures that financial decisions are aligned with the best interests of both investors and healthcare providers. By fostering collaboration and offering specialized financial expertise, NEXUSSURGL aims to drive innovation and improve access to quality healthcare. NEXUSSURGL distinguishes itself through its holistic approach, integrating financial acumen with a deep understanding of the healthcare industry's unique challenges and opportunities. The company provides a range of services, from financial consulting and investment management to strategic planning and capital acquisition. NEXUSSURGL's team of experienced professionals combines financial expertise with medical knowledge to offer comprehensive solutions that address the diverse financial needs of healthcare organizations. Through its commitment to excellence and a customer-centric approach, NEXUSSURGL seeks to be a trusted partner in driving the financial health and sustainable growth of the healthcare sector.
Company Details
Key Leadership
NEXUSSURGL Share Price: Frequently Asked Questions
What is the current share price of Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc (NEXUSSURGL) trades at ₹30.67 on NSE and BSE. Market cap ₹16.78 (Cr). Educational data only.
What is the P/E ratio of Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc has a P/E of 21.31x vs industry average 27.57x.
What is the Bull Run score for Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc has a Bull Run score of 63.8/100 based on 25+ financial parameters.
Does Nexus Surgical and Medicare Inc pay dividends?
Nexus Surgical and Medicare Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc has ROE of 51.69%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc has debt-to-equity of N/A.
Is Nexus Surgical and Medicare Inc a good investment?
Bull Run gives Nexus Surgical and Medicare Inc a score of 63.8/100. This is not investment advice — consult a SEBI-registered advisor.